ATLANTA, GA--(Marketwired - Jun 25, 2013) - The State of Georgia, through the Georgia Centers of Innovation Program (COI) and OneGeorgia Authority, has awarded the Georgia Institute of Technology a grant of almost $100,000 for ongoing work on Sensiotec Inc.'s innovative, non-contact cardiorespiratory monitoring technology platform.
Sensiotec, founded in 2008 and based at the Georgia Tech Venture Center in Atlanta, is readying its first product, the Virtual Medical Assistant® (VMA), for commercial launch. The VMA represents the world's first truly remote, totally non-contact, cardiorespiratory monitoring platform. Cleared for use with adults in hospitals and nursing homes, the VMA continuously acquires patient data at the point of care and processes it, streaming it to a server that both stores and makes the data available in real-time to end users.
The grant will fund further development of the network infrastructure and support final engineering work on the VMA. Sensiotec will match the amount of the grant.
"We are very grateful for the support Sensiotec has received from the State of Georgia, as well as from the state's research institutes," says Robert Arkin, Sensiotec's founder and Chief Executive Officer. "Sensiotec's non-contact sensing technology is truly a disruptive healthcare breakthrough that can help with better monitoring to benefit patients while also allowing medical teams to focus attention on patient care."
The grant will be used by a research team that encompasses public and private entities. Georgia Institute of Technology's Interactive Media Technology Center (IMTC), which is under the Office of Interdisciplinary Programs, will work closely with the Georgia Tech Research Institute (GTRI) as well as researchers in Georgia Tech's School of Electrical and Computer Engineering (ECE), College of Engineering (COE), the Smart Antenna Research Laboratory and the Mixed Signal Design Group.
"The Georgia Department of Economic Development and its Centers of Innovation programs are focused on encouraging academic research in collaboration with private industry to grow quality jobs in Georgia," says Glen Whitley, Director, Georgia Center of Innovation for Life Sciences and IT. "We are delighted to provide support for the Sensiotec technology which has strong potential to help patients here and across the nation."
Sensiotec Inc. has developed the Virtual Medical Assistant® (VMA), a truly remote, totally non-contact cardiorespiratory monitoring platform. Recalling the Star Trek Tricorder, the VMA provides critical 'spot' and 'trend' data continuously to a nurse's station or smart mobile device without electrodes touching the patient or requiring contact with a mattress or other surface (a/k/a standoff sensing). As a decision support tool, the VMA can help identify potential healthcare crises at an early stage and reduce complications associated with certain common chronic illnesses, helping providers to reduce risk, improve care and increase productivity. Cleared by the FDA for use with adults in hospitals and nursing homes, the VMA offers an extraordinary level of usability, scalability, interoperability and affordability compared to conventional telemetry systems. The VMA represents a disruptive scientific innovation with the potential to expand the proven benefits of continuous cardiorespiratory monitoring to a larger patient population at a fraction of today's costs. To learn more, visit www.sensiotec.com.